Patent Assignment
Reel/Frame 066647/0595
Security Interest
Recorded: 2024-03-05
Pages: 8
Assignors
XERIS PHARMACEUTICALS, INC.
Executed: 2024-03-05
STRONGBRIDGE DUBLIN LTD.
Executed: 2024-03-05
Assignee
HAYFIN SERVICES LLP
ONE EAGLE PLACE, LONDON, SW1Y 6AF, UNITED KINGDOM
Covered Properties
(17)
Methods for Producing Stable Therapeutic Formulations in Aprotic Polar Solvents
Application:
18/180,002 →
Publication:
US US20240041984A1
Treatment of Exercise-Induced Hypoglycemia in Type 1 and Insulin Using Type 2 Diabetes
Stable Therapeutic Compositions in Aprotic Polar Solvents and Methods of Manufacturing the Same
Stable Levothyroxine Compositions in Aprotic Polar Solvents
Application:
18/490,218 →
Publication:
US US20240148680A1
Sustained Release Injectable Therapeutic Formulations Using Aprotic Polar Solvents
Application:
18/490,224 →
Publication:
US US20240148678A1
Injectable High Concentration Pharmaceutical Formulations and Methods of Manufacturing and Use Thereof
Application:
17/930,857 →
Publication:
US US20230085357A1
Stable Formulations for Parenteral Injection of Small Molecule Drugs
Methods for Producing Stable Therapeutic Glucagon Formulations in Aprotic Polar Solvents
Precipitation Resistant Small Molecule Drug Formulations
Stable Therapeutic Compositions in Aprotic Polar Solvents and Methods of Manufacturing the Same
Methods of Treating Disease with Dichlorphenamide
Application:
18/453,937 →
Publication:
US US20230390227A1
Methods of Treating Disease with Levoketoconazole
Methods and Compositions for Treating Diabetes, Metabolic Syndrome and Other Conditions
Levoketoconazole for Treatment of Congenital Adrenal Hyperplasia and Primary Aldosteronism
Compositions and Methods of Use
Application:
17/151,405 →
Publication:
US US20210290542A1
Methods of Treating Disease with Levoketoconazole
Compositions and Methods for Treating Endocrine, Gastrointestinal or Autoimmune Disorders
Related Assignments
(20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 20, 2018
From: PRESTRELSKI, STEVEN; SANDOVAL, MICHAEL; DONOVAN, MARTIN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 045600/0969 →
Security Interest
Sep 12, 2019
From: XERIS PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 050362/0445 →
Assignment of Assignor's Interest
Aug 12, 2020
From: PRESTRELSKI, STEVEN; SCOTT, NANCY
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 053480/0851 →
Intellectual Property Security Agreement
May 4, 2021
From: XERIS PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 056135/0800 →
Assignment of Assignor's Interest
Aug 19, 2021
From: COHEN, FREDRIC
To: STRONGBRIDGE DUBLIN LIMITED
Reel/Frame 057230/0261 →
Assignment of Assignor's Interest
Oct 7, 2021
From: PRESTRELSKI, STEVEN J.; SANDOVAL, MICHAEL A.; SLOAT, BRIAN R.
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 057734/0034 →
Assignment of Assignor's Interest
Oct 28, 2021
From: COHEN, FREDRIC JAY
To: STRONGBRIDGE DUBLIN LIMITED
Reel/Frame 057953/0187 →
Security Interest
Mar 9, 2022
From: XERIS PHARMACEUTICALS, INC.; STRONGBRIDGE DUBLIN LIMITED
To: HAYFIN SERVICES LLP
Reel/Frame 059552/0066 →
Reassignment and Release of Security Interest
Mar 10, 2022
From: OXFORD FINANCE LLC
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 059358/0714 →
Reassignment and Release of Security Interest
Mar 10, 2022
From: OXFORD FINANCE LLC
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 059358/0700 →
Assignment of Assignor's Interest
Sep 16, 2022
From: DONOVAN, MARTIN; PRESTRELSKI, STEVEN; COLEMAN, SCOTT; SLOAT, BRIAN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 061115/0241 →
Assignment of Assignor's Interest
Nov 10, 2022
From: DONOVAN, MARTIN; HU, WENDY
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 061721/0694 →
Assignment of Assignor's Interest
Dec 18, 2023
From: COHEN, FREDRIC
To: STRONGBRIDGE DUBLIN LIMITED
Reel/Frame 065896/0380 →
Assignment of Assignor's Interest
Feb 13, 2024
From: DONOVAN, MARTIN; HU, WENDY
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 066449/0925 →
Assignment of Assignor's Interest
Feb 26, 2024
From: DONOVAN, MARTIN; HU, WENDY; FITCH, RICHARD; PRESTRELSKI, STEVEN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 066557/0901 →
Assignment of Assignor's Interest
Feb 26, 2024
From: DONOVAN, MARTIN; FITCH, RICHARD; PRESTRELSKI, STEVEN
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 066557/0964 →
Assignment of Assignor's Interest
Dec 9, 2024
From: COHEN, FRED
To: STRONGBRIDGE DUBLIN LIMITED
Reel/Frame 069523/0398 →
Assignment of Assignor's Interest
May 8, 2025
From: STRONGBRIDGE DUBLIN LIMITED
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 071065/0961 →
Assignment of Assignor's Interest
May 9, 2025
From: STRONGBRIDGE DUBLIN LIMITED
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 071072/0969 →
Assignment of Assignor's Interest
Nov 24, 2025
From: PRESTRELSKI, STEVEN; NEWSWANGER, BRETT; CUMMINS, MARTIN; RIDDELL, MICHAEL
To: XERIS PHARMACEUTICALS, INC.
Reel/Frame 073022/0053 →